Response to Letter on "Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol"

Susanna Stjerna; Yfke Huber-Mollema; Torbjörn Tomson; Emilio Perucca; Dina Battino; John Craig; Anne Sabers; Sanjeev Thomas; Frank Vajda; Eija Gaily

doi:10.1016/j.yebeh.2024.110084

Response to Letter on "Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol"

Susanna Stjerna^*, Yfke Huber-Mollema, Torbjörn Tomson, Emilio Perucca, Dina Battino, John Craig, Anne Sabers, Sanjeev Thomas, Frank Vajda, Eija Gaily

^*Corresponding author for this work

Department of Neurology

2 Citations (Scopus)

Original language	English
Article number	110084
Journal	Epilepsy and Behavior
Volume	160
ISSN	1525-5050
DOIs	https://doi.org/10.1016/j.yebeh.2024.110084
Publication status	Published - 2024

Access to Document

10.1016/j.yebeh.2024.110084

Cite this

Stjerna, S., Huber-Mollema, Y., Tomson, T., Perucca, E., Battino, D., Craig, J., Sabers, A., Thomas, S., Vajda, F., & Gaily, E. (2024). Response to Letter on "Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol". Epilepsy and Behavior, 160, Article 110084. https://doi.org/10.1016/j.yebeh.2024.110084

Response to Letter on "Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol". / Stjerna, Susanna; Huber-Mollema, Yfke; Tomson, Torbjörn et al.
In: Epilepsy and Behavior, Vol. 160, 110084, 2024.

Research output: Contribution to journal › Comment/debate › Research › peer-review

Stjerna, S, Huber-Mollema, Y, Tomson, T, Perucca, E, Battino, D, Craig, J, Sabers, A, Thomas, S, Vajda, F & Gaily, E 2024, 'Response to Letter on "Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol"', Epilepsy and Behavior, vol. 160, 110084. https://doi.org/10.1016/j.yebeh.2024.110084

@article{faaa8d3f56364360bfb0bb656546a181,

title = "Response to Letter on {"}Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol{"}",

author = "Susanna Stjerna and Yfke Huber-Mollema and Torbj{\"o}rn Tomson and Emilio Perucca and Dina Battino and John Craig and Anne Sabers and Sanjeev Thomas and Frank Vajda and Eija Gaily",

year = "2024",

doi = "10.1016/j.yebeh.2024.110084",

language = "English",

volume = "160",

journal = "Epilepsy and Behavior",

issn = "1525-5050",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Response to Letter on "Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy

T2 - Data from the EURAP neurocognitive extension protocol"

AU - Stjerna, Susanna

AU - Huber-Mollema, Yfke

AU - Tomson, Torbjörn

AU - Perucca, Emilio

AU - Battino, Dina

AU - Craig, John

AU - Sabers, Anne

AU - Thomas, Sanjeev

AU - Vajda, Frank

AU - Gaily, Eija

PY - 2024

Y1 - 2024

UR - https://www.scopus.com/pages/publications/85206081311

U2 - 10.1016/j.yebeh.2024.110084

DO - 10.1016/j.yebeh.2024.110084

M3 - Comment/debate

C2 - 39413684

SN - 1525-5050

VL - 160

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

M1 - 110084

ER -

Response to Letter on "Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol"

Access to Document

Other files and links

Cite this